56 assets in Mesothelioma

Therapeutic assets addressing Mesothelioma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Obinutuzumab Mesothelioma	NeoTX Therapeutics Ltd.	P1	C (39)
pf-08046049 Mesothelioma	Seagen, a wholly owned subsidiary of Pfizer	P1	C (39)
pf-08052666 Mesothelioma	Seagen, a wholly owned subsidiary of Pfizer	P1	C (39)
kt032 Mesothelioma	Weijia Fang, MD	Early P1	C (38)
Milademetan Mesothelioma	Rain Oncology Inc	P1/2	C (32)

Showing 51 to 56 of 56 assets

PreviousPage 2 of 2Next